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ABSTRACT: A direct, ambient ionization method has been developed for the determination of
creatinine in urine that combines derivatization and thermal desorption with extractive electrospray
ionization and ion mobility-mass spectrometry. The volatility of creatinine was enhanced by a rapid
on-probe aqueous acylation reaction, using a custom-made thermal desorption probe, allowing thermal
desorption and ionization of the monoacylated derivative. The monoacyl creatinine [M + H]+ ion (m/
z 156) was subjected to mass-to-charge selection and collision induced dissociation to remove the acyl
group, generating the protonated creatinine [M + H]+ product ion at m/z 114 before an ion mobility
separation was applied to reduce chemical noise. Stable isotope dilution using creatinine-d3 as internal
standard was used for quantitative measurements. The direct on-probe derivatization allows high
sample throughput with a typical cycle time of 1 min per sample. The method shows good linearity
(R2 = 0.986) and repeatability (%RSD 8−10%) in the range of 0.25−2.0 mg/mL. The creatinine concentrations in diluted urine
samples from a healthy individual were determined to contain a mean concentration of 1.44 mg/mL creatinine with a precision
(%RSD) of 9.9%. The reactive ambient ionization approach demonstrated here has potential for the determination of involatile
analytes in urine and other biofluids.
Thermal desorption is a commonly used method for thegeneration of gaseous phase analytes from less volatile
matrix components. The process of directly heating a sample to
liberate molecules from the liquid phase has been widely
applied to the analysis of volatile organic compounds (VOCs)
by headspace gas chromatography (GC).1 Other applications of
thermal desorption include headspace analysis by mass
spectrometry (MS)2 and narcotic/explosive detection by ion
mobility (IM) spectrometry.3 The application of thermal
desorption is limited by the volatility of the target analyte,
which can be altered by specific derivatization reactions.4−6
The substitution reactions of alkylation, acylation, and
silylation5 can significantly reduce the temperatures required
for thermal desorption of a molecule. However, these reactions
are generally carried out in a nonaqueous environment. The
process of removing the water from a sample prior to
derivatization enables a wide range of derivatization reactions
to be carried out but significantly increases the sample
preparation time required for each analysis. The use of aqueous
based derivatization reactions overcomes the difficulties
associated with aqueous samples, allowing direct derivatiza-
tion.6 The use of aqueous derivatization reactions for the
detection of compounds in urine has been an area of interest,
particularly in the analysis of drugs of abuse,7,8 but the
technique is still in its infancy for biomedical prognostic/
diagnostic applications.9
The direct analysis of urine by electrospray ionization mass
spectrometry is problematic, because of ion suppression effects
arising from the high salt content of urine.10 Prior separation by
high performance liquid chromatography (HPLC) or GC,
hyphenated with MS, is therefore usually used for the detection
of excreted metabolites relating to disease states such as lung
disorder, diabetes, and cancer.11−13 It is common practice in
the determination of urinary metabolites to normalize the
target molecule concentration to the excretion of creatinine.14
The normalization process allows the absolute amount of an
excreted metabolite to be expressed in relation to the creatinine
level (i.e., μg/g creatinine) which can then be used as a
comparison against a healthy population. The concentration of
creatinine in both urine and blood serum is dependent on
several variables, including the glomerular filtration rate, which
is itself dependent on age, gender, and body size.15,16 The
measurement of the creatinine clearance rate (CrCl), the
amount of creatinine passed in 24 h, determines the glomerular
filtration rate (GFR) which also provides information on
kidney function.
A variety of methods are available for the determination of
creatinine (I, below) in urine, the most widely used being the
Jaffe reaction.17
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This colorimetric based approach places serum or urine in an
alkaline environment to facilitate the reaction between
creatinine and picric acid to form red/orange crystals. The
poor specificity of the Jaffe reaction limits its use, particularly in
serum, and has therefore been modified numerous times to
increase the specificity of the method.18 Other methods include
a two-step enzymatic digestion of creatinine,19 which has higher
selectivity compared to the Jaffe reaction but is limited by a
complex multiple step sample preparation procedure and
involves ion exchange chromatography.20 Creatinine determi-
nation in complex biofluids has been previously performed by
GC/MS with isotope dilution, using a derivatization step to
increase analyte volatility.21 The direct determination of urinary
creatinine levels by extractive electrospray (EESI)-tandem mass
spectrometry has also been demonstrated,22 showing that
ambient ionization can be used to measure urinary creatinine
with high sensitivity. However, this approach does not separate
the target analyte from the urine matrix prior to ionization and
may be susceptible to interference and ion suppression effects.
Thermal desorption of a volatile target molecule allows
ionization by EESI23 while discriminating against the urinary
salts and other underivatized metabolites. Here, the combina-
tion of a rapid aqueous phase derivatization to promote
desorption of an involatile analyte directly from the urine
matrix, combined with EESI and ion mobility mass
spectrometry (IM-MS) of the volatile derivative, is demon-
strated for the determination of creatinine. This approach has
wider application as an ambient ionization method for the
rapid, direct quantitation of involatile urinary analytes
unaffected by ion suppression from salts and other
components.
■ EXPERIMENTAL SECTION
Chemicals. Analytical grade water and methanol were
purchased from Fisher Scientific (Loughborough, UK). HPLC
grade formic acid, acetic anhydride (99%), and creatinine
(98%) were purchased from Sigma Aldrich (Gillingham, UK).
Creatinine-d3 was purchased from Toronto Research Chemicals
Inc. (Ontario, Canada). All chemicals were used without further
purification.
AP/TD Probe. A schematic diagram of the ion source region
of a Waters Synapt HDMS spectrometer (Waters, Manchester,
UK), modified in-house for direct on-probe reactive derivatiza-
tion (R-TD) and extractive electrospray is shown in Figure 1.24
The TD probe was constructed by placing a cylindrical heater
cartridge (2.5 mm o.d. × 50 mm; RS Components Ltd.,
Northants, UK) into a stainless steel tube (12 i.d. × 300 mm)
with the heater positioned inside an aluminum adaptor at the
probe tip. Samples and the derivatization reagent were injected
into a brass sample holder (2.5 mm o.d. × 10 mm) located
within the aluminum adaptor, with the base of the sample
holder in direct contact with the heater cartridge. The sample
holder was inserted through a hole in the side of a stainless steel
tube (12 mm o.d. × 50 mm) located between the ESI probe
and the mass spectrometer inlet cone that spatially confines the
thermally desorbed analytes for ionization by an in-line
electrospray plume. The cartridge temperature was regulated
using a temperature controller (Tempatron, Reading UK) to
set the sample holder temperature to 100 °C.
Sample Preparation. Creatinine standards were prepared
in water at concentrations in the range of 2.5−20 μg/mL (60
μL). Urine samples were diluted with water (1:100), and
deuterated creatinine-d3 was added at a concentration of 5 μg/
mL (40 μL). In preliminary creatinine acylation experiments,
urine was mixed with acetic anhydride (100 μL) at a 1:1 ratio to
initiate the acylation reaction. The samples were continually
agitated, and aliquots (10 μL) of the reaction mixture were
removed, diluted in 50:50 methanol/water (1:10) with 0.1%
formic acid, and directly infused into the ESI source of the mass
spectrometer. On-probe derivatization was carried out by the
direct injection of a mixture of diluted urine (10 μL of a 1:100
dilution in water), containing the creatinine-d3 internal
standard, and acetic anhydride (10 μL) into the sample holder
of the TD probe, which was preheated to 100 °C.
EESI-IM-MS/MS Conditions. The EESI solvent consisted
of 50:50 MeOH/H2O (v/v) with 0.1% formic acid (v/v), which
was infused from a syringe pump at a flow rate of 10 μL/min.
The mass spectrometer (Synapt HDMS, Waters, Manchester,
UK) was operated in sensitivity (V) mode using positive
ionization with a capillary voltage of 2.8 kV and a cone voltage
of 15 V; a mass range of m/z 50−500 was monitored. The
source temperature was set to 120 °C, with a nebulizer gas flow
(N2) of 60 L/h. The quadrupole was set to transmit the
monoacylated creatinine ([M + H]+ = m/z 156) and creatinine-
d3 ([M + H]
+ = m/z 159) ions. The trap region of the Waters
Tri-Wave cell was set to 13 V for collision induced dissociation
of the mass-selected precursor ions using N2 as the collision
gas. The traveling wave ion mobility (TWIM) cell wave height
was 6 V; the wave velocity was 300 m/s, and the N2 drift gas
was set to 30 mL/min. The TOF pusher pulse interval was 45
μs/scan; 200 TOF scans were taken per IM spectrum providing
a drift time range of 0−9 ms.
■ RESULTS AND DISCUSSION
The aqueous derivatization of urinary creatinine by acetic
anhydride was initially investigated off-line using urine spiked
Figure 1. Schematic diagram of the R-TD-EESI-MS ion source region
(not to scale).
Analytical Chemistry Technical Note
dx.doi.org/10.1021/ac403133t | Anal. Chem. 2014, 86, 357−361358
Figure 2. ESI-MS/MS spectrum showing the CID fragmentation of the [M + H]+ ions of monoacylated creatinine and creatinine-d3 (m/z 156 and
159, respectively) post-three hour reaction generating the protonated creatinine and creatinine-d3 product ions at m/z 114 and 117.
Figure 3. R-TD-EESI-IM-MS/MS selected ion responses from the analysis of urine (a) creatinine fragment (m/z 114) and (b) creatinine-d3
fragment (m/z 117), (c) summed MS data (full width half height), and (d) IM drift profile for urinary creatinine (Bin Number 36, Drift Time = 1.6
ms).
Analytical Chemistry Technical Note
dx.doi.org/10.1021/ac403133t | Anal. Chem. 2014, 86, 357−361359
with creatinine-d3. The resulting solution was mixed 1:1 with
acetic anhydride and allowed to react at room temperature for 3
h. Aliquots of the reaction mixture were removed, diluted, and
directly infused into the ESI source of the mass spectrometer.
The [M + H]+ responses for the monoacylated urinary
creatinine and creatinine-d3 were observed at m/z 156 and m/z
159, respectively (Figure 2), demonstrating the derivatization of
creatinine in an aqueous environment. The monoacylated ions
were mass-selected and fragmented by collision-induced
dissociation, resulting in the formation of fragment ions at
m/z 114 and 117, which correspond to protonated creatinine
and creatinine-d3, following loss of the acetyl group, confirming
the identification of the monoacyl derivatives. The direct
infusion data also shows two unidentified ions present at m/z
135 and 153, associated with the urine matrix.
The direct on-probe acylation of urinary creatinine was
tested under thermal desorption conditions on the TD probe to
determine the volatility of the monoacyl derivative. An aliquot
of diluted urine was mixed with acetic anhydride (1:1) and
immediately injected into the preheated (100 °C) TD probe
sample holder. The vapor plume generated by TD was
contained by the stainless steel tube interface (Figure 1) and
ionized by interaction of the vaporized analytes with the
electrospray droplets, a process that has been termed as
extractive electrospray.25
The direct reactive derivatization-thermal desorption (R-TD)
of urinary creatinine in the presence of acetic anhydride
generates a near instantaneous response for the monoacylcrea-
tinine ([M + H]+ m/z 156) and the protonated creatinine
fragment ion (m/z 114). Injection of an aliquot of urine
without acetic anhydride resulted in a small baseline response
with a peak area <0.4% of the response in the presence of the
derivatizing agent. These results show that the acylation
significantly increases the volatility of creatinine from a
decomposition point of ∼300 °C to less than the TD probe
temperature of 100 °C and that the reaction is sufficiently rapid
to allow direct on-probe derivatization and thermal desorption.
Since only volatile molecules and derivatives capable of being
thermally desorbed at 100 °C will interact with the ESI plume,
ion suppression by the urine matrix, observed when diluted
urine is directly infused into an ESI ion source,10 is avoided by
this R-TD ambient ionization approach.
Selectivity in the determination of creatinine was achieved
preionization by R-TD and postionization by IM and tandem
mass spectrometry to reduce chemical noise. Typical data
obtained for the analysis of urine containing creatinine and
creatinine-d3 incorporating an ion mobility-tandem mass
spectrometry separation after mass selection of the mono-
acylated ions are shown in Figure 3.
The selected ion responses for the protonated creatinine (m/
z 114) and creatinine-d3 (m/z 117) fragment ions (Figure
3a,b), from the R-TD-EESI-IM-MS/MS analysis of the mass-
selected monoacylated derivatives, show the effective fragmen-
tation of the acyl derivatives at m/z 156 and m/z 159. The mass
spectrum obtained by averaging spectra across the width of the
selected ion response (SIR) peak at half height (Figure 3c)
shows the protonated creatinine and creatinine-d3 fragment
ions. The identification of creatinine was confirmed by accurate
mass measurement of the [M + H]+ ion (m/z 114.0663, mass
accuracy 3.5 ppm) using creatinine-d3 as reference standard.
The inset (Figure 3d) shows the mass-selected ion mobility
spectrum for m/z 114 fragment ion. The drift time of an ion is
determined by the collision cross section (i.e., size and shape)
of the ion as it passes through the TWIMS drift cell in the
presence of a buffer gas (N2) and under the influence of
traveling wave electric field.26,27 The drift profiles for the
urinary creatinine and creatinine-d3 have a peak maxima
corresponding to a drift time of 1.62 ms, that matches the
drift time obtained from creatinine standards. The time for the
ion mobility separation is short (9 ms) compared to the
creatinine desorption profile time (peak width at half height ∼3
s) allowing the acquisition of sufficient data points across the
desorption profile. The combination of high resolution tandem
mass spectrometry and ion mobility separation provides
selectivity that supports the use of the direct derivatization
and ambient ionization without prior chromatographic
separation for the rapid determination of urinary creatinine.
The quantitative response for creatinine standards, spiked
with creatinine-d3 (5 μg/mL), determined by R-TD-EESI-IM-
MS/MS was linear in the range of 2.5−20 μg/mL (R2 = 0.986)
based on the peak area ratios from six replicate injections for
Figure 4. The selected ion responses for (a) urinary creatinine fragment (m/z 114) and (b) creatinine-d3 fragment (m/z 117) from six replicate
injections of a 1:1 mixture of urine, spiked with creatinine-d3, and acetic anhydride using the R-TD-EESI-IM-MS/MS method.
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each point in the calibration curve. This corresponds to
endogenous creatinine levels of 0.25−2 mg/mL in urine with
the dilution taken into account. The limit of detection was 0.4
μg/mL (signal/noise, 3:1), and the limit of quantitation was
determined to be 1.35 μg/mL (signal/noise, 10:1).
The potential for the rapid, high throughput determination
of urinary creatinine was evaluated using replicate aliquots of
diluted urine, mixed with acetic anhydride prior to injection at
one minute intervals and analysis by R-TD-EESI-IM-MS/MS.
Figure 4 shows the SIR responses for the urinary creatinine (m/
z 114) and creatinine-d3 (m/z 117) fragments ions in the drift
time region of 1.58−1.67 ms, obtained from the analysis. The
thermal desorption process generates sharp desorption profiles
with high intensity and peak widths of ∼3 s. The peaks show
some tailing, but for each injection, the creatinine response
returns to baseline before the next injection, demonstrating that
there is no carry over between samples.
The six urine injections produced responses within the
calibrated range with a mean creatinine concentration in the
diluted urine of 14.42 μg/mL. The dilution factor (1:100) gives
a urine concentration of 1.44 mg/mL, which is within the
normal urinary creatinine range based upon the donor (healthy
male, 30 years of age). The precision of the R-TD-EESI-IM-
MS/MS technique was determined as 9.9% RSD from six
replicate measurements of urine.
■ CONCLUSIONS
The determination of urinary creatinine has been performed by
a direct on-probe aqueous acylation prior to thermal desorption
and extractive electrospray-ion mobility-mass spectrometry.
The rapid acylation of creatinine to its monoacyl derivative
increases the volatility of the molecule enabling rapid thermal
desorption. The selective determination of creatinine was
achieved preionization by derivatization and thermal desorption
and postionization by ion mobility separation and tandem mass
spectrometry. Quantification was carried out by the use of
stable isotope dilution with creatinine-d3 over the range of 2.5−
20 μg/mL with %RSDs ranging from 8 to 10% for replicate
injections. The direct ambient ionization method allowed high
sample throughput, with an injection to injection time of 1 min.
The derivatization-thermal desorption approach is demonstra-
ted here for the determination of creatinine but could be
applied to other involatile compounds present in complex
matrices through the use of specific derivatizing agents to
promote volatility and desorption of a target molecule, enabling
direct quantitation while reducing background matrix interfer-
ence.
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